ReviewPharmaceuticals (Basel, Switzerland)2023

Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4).

Marwa M QadriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.